Viewing Study NCT00078195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-27 @ 11:54 AM
Study NCT ID: NCT00078195
Status: COMPLETED
Last Update Posted: 2016-10-18
First Post: 2004-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hay Fever View
None Hypersensitivity View
None Allergy View
None Rhinitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ragweed View
None Immunotherapy View
None Rush Immunotherapy View
None RIT View
None Hayfever View
None Seasonal Allergic Rhinitis View